TREM2 and early-onset autosomal dominant Alzheimer disease: Overexpression of TREM2 in an Alzheimer’s disease transgenic mouse model significantly ameliorates Alzheimer’s disease-related neuropathology, including Aβ deposition, neuroinflammation, and synaptic losses, which is accompanied by improved spatial cognitive functions [17].